Response to: Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
J Glaucoma
.
2020 Jun;29(6):e55.
doi: 10.1097/IJG.0000000000001500.
Authors
Jeanette Du
1
,
James T Patrie
2
,
Bruce E Prum
3
,
Peter A Netland
3
,
Yevgeniy Eugene Shildkrot
3
Affiliations
1
University of Virginia School of Medicine.
2
Departments of Public Health Sciences.
3
Ophthalmology, University of Virginia Charlottesville, VA.
PMID:
32217997
DOI:
10.1097/IJG.0000000000001500
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Glaucoma*
Humans
Intraocular Pressure*
Ranibizumab
Substances
Bevacizumab
Ranibizumab